<DOC>
	<DOC>NCT00861458</DOC>
	<brief_summary>This study will test two different formulations. The results will be used to select formulation for phase 3.</brief_summary>
	<brief_title>Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy volunteers. Standard for healthy volunteers.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>